ArticleFrontiers in public health2025
An extreme value analysis of daily new cases of COVID-19 in Africa.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modeling COVID-19 cases in Africa is crucial for developing effective public health strategies, allocating resources efficiently, and mitigating the impact of the pandemic on vulnerable populations. A recent paper by the first author provided an extreme value analysis of daily new cases of COVID-19 from sixteen countries in west Africa. In this paper, we broaden our analysis to encompass data spanning all fifty four African nations over a period of forty four months. We identified extreme values as the monthly maximums of daily new cases. Utilizing the generalized extreme value distribution, we fitted the data, allowing two of its three parameters to vary linearly or quadratically in relation to the month number. Twenty six countries demonstrated significant downward trends in monthly maximums. Two countries demonstrated significant upward trends in monthly maximums. Nineteen countries demonstrated significant quadratic trends where monthly maximums initially increased before decreasing. The sharpest and weakest of the downward trends with respect to location were for Mali and Liberia, respectively. The sharpest and weakest of the downward trends with respect to scale were for Egypt and Libya, respectively. Recommendations are given for each country. We evaluated the adequacy of fits through probability plots and the Kolmogorov-Smirnov test. Subsequently, the fitted models were employed to determine quantiles of the monthly maximum of new cases, as well as their limits extrapolated to infinite month numbers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.